It doesn't get any better than having a customer, industry analyst and a 3rd-party technology writer to all concur and give a thumbs up to your solution and strategy.
Novell's SUSE Linux Enterprise (with VMWare VMI support) and Platespin making the headlines today at SearchEnterpriseLinux ( http://searchenterpriselinux.techtarget.com/news/article/0,289142,sid39_gci1321810,00.html )
Invitrogen Corp., a $1.3 billion life sciences firm based in Carlsbad, Calif., decided to adopt Novell SUSE Linux Enterprise as its platform of choice.
John Merritt said: "This conversion to SUSE isn't because we love open source. It's not about what's cool. It's because it's the right thing to do for the company."
SUSE allows unlimited virtualization, either on Citrix Systems Inc.'s Xen or VMware Inc., he said. This became an important differentiator for Novell. Red Hat was 40% more expensive than SUSE; in fact, it was more expensive than Windows...
Another advantage of Novell was Novell's March acquisition of PlateSpin ... Merritt said is the only tool that will perform physical-to-virtual migrations on Linux.
Burton Group's Jones said the two top open source rivals have adopted fundamentally different market strategies, with Red Hat committed to all-open source products and Novell adopting a best-of-breed, open or proprietary philosophy that focuses on whatever's best for the customer.